The trial is ongoing at multiple centers in the United States, the European Union, and the United Arab Emirates. This trial ...

Interleukin-17 therapy for hidradenitis suppurativa was not associated with an increased risk for inflammatory bowel disease, according to a study published in JAMA Dermatology. Of the 2,572 patients ...

Randomized controlled trials remain the most effective tool in the pharmaceutical industry’s evidence-generation toolkit. They are crucial for demonstrating novel drugs' safety and efficacy, assessing ...

Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3 A total of 160 patients ...

Spyre Therapeutics, Inc. (NASDAQ:SYRE) reported September 8 results from 44 patients with moderately to severely active ...

If you knew which foods had the biggest impact, would you choose differently? (Tero Vesalainen/Canva) Changing people's ...

A prospective randomized controlled trial of an aesthetic EMS platform to assess objective functional performance reports improvements across four standardized tests ...

Tesamorelin can selectively reduce visceral fat, as demonstrated in RCTs. But the real story is what it reveals about metabolism, peptides, and the future of self-driven health experimentation.